BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 28, 2000
View Archived Issues
NCI awards grant to conduct genetic studies of colon cancer
Read More
Milestone reached in MorphoSys and GPC Biotech immunology therapeutics program
Read More
MVA vaccine approved for U.K. trials; Kenyan trials expected to follow
Read More
Immunomedics commences phase III clinical trial with LymphoCide
Read More
Simdax approved in Sweden for severe heart failure
Read More
Sangamo and Rosetta to study new therapeutic agents
Read More
Trial of novel restenosis treatment AGI-1067 set to begin
Read More
NDA submitted for combined niacin/lovastatin cholesterol product
Read More
Submission of NDA for lupus therapy completed by Genelabs
Read More
CP-654743: a semisynthetic fluorinated ketolide derivative with potential in respiratory infections
Read More
DHA shows potent, dose-dependent neuroprotection in animal model of stroke
Read More
Topical formulation of Targretin launched in U.S. for CTCL therapy
Read More
Welfide pursues a novel therapeutic approach to psychotic symptoms
Read More
Abgenix to acquire ImmGenics
Read More
Asta Medica presents synthesis and characterization of AWD-34-022, a new anticonvulsant
Read More
Ferrer selects new development candidate for the treatment of hypertension
Read More
Ilex Oncology's first angiogenesis inhibitor enters phase I in France
Read More
Preliminary profile of Esteve's E-6006 indicates potential as antidepressant
Read More
Encouraging antitumor activity reported for IGT Pharma's AVLB
Read More
Series of cdk inhibitors described in Pharmacia patent
Read More
Tissue-selective estrogens patented by Schering
Read More
Potential antimigraine agents discovered at Lilly
Read More
Novel class of sulfonamides synthesized at Vertex act as inhibitors of HIV protease
Read More
Stable and safe antineoplastic agents developed at Ohio State University
Read More
Novel cathepsin K inhibitors reportedly useful for osteoporosis
Read More
AstraZeneca's new cysteine protease inhibitors claimed for COPD
Read More